Ginkgo Bioworks Holdings Inc (DNA)
0.955
+0.09
(+10.90%)
USD |
NYSE |
May 03, 16:00
0.94
-0.02
(-1.57%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Price: 0.955 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 0.909 | 1.00 | 0.8899 | 0.955 | 54.44M |
May 02, 2024 | 0.8781 | 0.91 | 0.82 | 0.8611 | 49.76M |
May 01, 2024 | 0.8846 | 0.9192 | 0.7907 | 0.8421 | 86.18M |
Apr 30, 2024 | 0.98 | 1.01 | 0.891 | 0.8911 | 66.21M |
Apr 29, 2024 | 0.8601 | 1.13 | 0.86 | 0.9898 | 75.57M |
Apr 26, 2024 | 0.7782 | 0.87 | 0.7551 | 0.8601 | 71.22M |
Apr 25, 2024 | 0.821 | 0.821 | 0.7403 | 0.7777 | 72.79M |
Apr 24, 2024 | 0.89 | 0.895 | 0.8168 | 0.8458 | 45.52M |
Apr 23, 2024 | 0.835 | 0.9328 | 0.835 | 0.8705 | 55.62M |
Apr 22, 2024 | 0.8507 | 0.8715 | 0.81 | 0.8428 | 52.00M |
Apr 19, 2024 | 0.9135 | 0.9387 | 0.851 | 0.8649 | 38.94M |
Apr 18, 2024 | 0.866 | 0.9541 | 0.852 | 0.9246 | 39.28M |
Apr 17, 2024 | 0.9177 | 0.948 | 0.85 | 0.8716 | 43.76M |
Apr 16, 2024 | 0.94 | 0.9598 | 0.9033 | 0.9135 | 30.11M |
Apr 15, 2024 | 1.03 | 1.03 | 0.925 | 0.95 | 44.07M |
Apr 12, 2024 | 1.06 | 1.07 | 1.01 | 1.01 | 14.17M |
Apr 11, 2024 | 1.12 | 1.15 | 0.9928 | 1.05 | 50.94M |
Apr 10, 2024 | 1.10 | 1.14 | 1.09 | 1.12 | 15.69M |
Apr 09, 2024 | 1.11 | 1.19 | 1.11 | 1.16 | 20.38M |
Apr 08, 2024 | 1.07 | 1.12 | 1.07 | 1.11 | 14.58M |
Apr 05, 2024 | 1.06 | 1.10 | 1.05 | 1.08 | 16.11M |
Apr 04, 2024 | 1.10 | 1.13 | 1.07 | 1.07 | 15.25M |
Apr 03, 2024 | 1.05 | 1.12 | 1.03 | 1.09 | 17.01M |
Apr 02, 2024 | 1.10 | 1.11 | 1.03 | 1.05 | 27.12M |
Apr 01, 2024 | 1.18 | 1.19 | 1.08 | 1.12 | 17.87M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.7777
Minimum
Apr 25 2024
14.92
Maximum
Nov 08 2021
4.278
Average
2.49
Median
Jun 22 2022
Price Benchmarks
Agenus Inc | 13.07 |
Teladoc Health Inc | 12.78 |
Sarepta Therapeutics Inc | 133.66 |
Ultragenyx Pharmaceutical Inc | 42.75 |
Apellis Pharmaceuticals Inc | 47.46 |
Price Related Metrics
PS Ratio | 7.390 |
Price to Book Value | 1.918 |
Earnings Yield | -49.19% |
Market Cap | 2.105B |